Genetic polymorphisms of glutathione S-transferases are associated with ulcerative colitis in central China

Cell Biochemistry and Biophysics

Volumn 60, Issue 3, 2011, Pages 323-328

  Ye, Xujun ^a   Jiang, Yi ^b   Wang, Hua ^a   Chen, Ling ^a   Yuan, Sheng ^a   Xia, Bing ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Genetic polymorphism; Genetic predisposition; Glutathione S transferase; Ulcerative colitis

Indexed keywords

GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; ALLELE; ARTICLE; ASIAN; CHINA; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; ULCERATIVE COLITIS;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 79958270206     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9154-z     Document Type: Article

References (35)

1. Andres, P. G., & Friedman, L. S. (1999). Epidemiology and the natural course of inflammatory bowel disease. Gastroenterology Clinics of North America, 28, 255-281.
2. Fiocchi, C. (1998). Inflammatory bowel disease: aetiology, pathogenesis. Gastroenterology, 115, 182-205.
3. Ogura, Y., Bonen, D. K., Inohara, N., et al. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-606.
4. Hugot, J. P., Chamaillard, M., Zouali, H., et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
5. Tumer, Z., Croucher, P. J., Jensen, L. R., et al. (2002). Genomic structure, chromosome mapping and expression analysis of the human AVIL gene, and its exclusion as a candidate for locus for inflammatory bowel disease at 12q13-14 (IBD2). Gene, 288, 179-185.
6. Duerr, R. H., Taylor, K. D., Brant, S. R., et al. (2006). A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science, 314, 1461-1463.
7. van Limbergen, J., Russell, R. K., Nimmo, E. R., et al. (2007). Genetics of the innate immune response in inflammatory bowel disease. Inflammatory Bowel Diseases, 13, 338-355.
8. Young, Y., & Abreu, M. T. (2006). Advances in the pathogenesis of inflammatory bowel disease. Current Gastroenterology Reports, 8, 470-477.
9. Pemble, S., Schroeder, K. R., Spencer, S. R., et al. (1994). Human glutathione S-transferase u (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochemical Journal, 300, 271-276.
10. Seidegard, J., Pero, R. W., Markowitz, M. M., et al. (1990). Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis, 11, 33-36.
11. Hu, X., Ji, X., Srivastava, S. K., et al. (1997). Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Archives of Biochemistry and Biophysics, 345, 32-38.
12. Sundberg, K., Johansson, A. S., Stenberg, G., et al. (1998). Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 19, 433-436.
13. Lennard-Jones, J. E. (1989). Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology Supplement, 24, 2-6.
14. Truelove, S. C., & Witts, L. J. (1955). Cortisone in ulcerative colitis: final report on a therapeutic trial. British Medical Journal, 2, 1042-1048.
15. Curran, J. E., Weinstein, S. R., & Griffiths, L. R. (2000). Polymorphisms of glutathione transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Letters, 153, 113-120.
16. Hirvonen, A. (1999). Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environmental Health Perspectives, 107(Suppl 1), 37-47.
17. Pinarbasi, H., Silig, Y., & Gurelic, M. (2005). Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genetics and Cytogenetics, 156, 144-149.
18. Rebbeck, R. T. (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiology, Biomarkers and Prevention, 6, 733-743.
19. Lear, J., Heagerty, A., Smith, A., et al. (1996). Polymorphism in detoxifying enzymes and susceptibility to skin cancer. Photochemistry and Photobiology, 63, 424-428.
20. Helzlsouer, K. J., Selmin, O., Hung, H., et al. (1998). Association between glutathione S-transferase M1, P1 and T1 genetic polymorphisms and development of breast cancer. Journal of the National Cancer Institute, 90, 512-518.
21. Zhong, S., Wyllie, A. H., Barnes, D., et al. (1994). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 1821-1824.
22. Trizna, Z., Clayman, G. L., Spitz, M. R., et al. (1995). Glutathione S-transferase genotypes as risk factors for head and neck cancer. American Journal of Surgery, 170, 499-501.
23. Pinarbasi, H., Silig, Y., Cetinkaya, O., et al. (2003). Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genetics and Cytogenetics, 146, 125-129.
24. d'Errico, A., Tailor, J. A., Chen, X., et al. (1996). Genetic metabolic polymorphisms and the risk of cancer, a review of the literature. Biomarkers, 1, 149-173.
25. Ryberg, D., Skaug, V., Hewer, A., et al. (1997). Genotypes of glutathione S-transferase M1 and P1 and their significance for lung DNA adduct levers and cancer risk. Carcinogenesis, 18, 1285-1289.
26. Nelson, H. H., Wienche, J. K., Christiani, D. C., et al. (1995). Ethnic differences in the prevalence of the deleted genotype of glutathione S-transferase theta. Carcinogenesis, 16, 1243-1245.
27. Lee, E. J., Wong, J. Y., Yeoh, P. N., et al. (1995). Glutathione S-transferase theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics, 5, 332-334.
28. Kelsey, K. T., Wrensch, M., Zuo, Z. F., et al. (1997). A population based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors. Pharmacogenetics, 7, 463-468.
29. Elexpuru, C. J., Buxton, N., Kandula, V., et al. (1995). Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P450(CYP2D6) loci. Cancer Research, 55, 4237-4239.
30. Deakin, M., Elder, J., Hendrickse, D., et al. (1996). Glutathione S-transferase T1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis, 17, 881-884.
31. Watson, M. A., Stewart, R. K., Smith, G. B., et al. (1998). Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis, 19, 275-280.
32. Ye, Z., & Song, H. (2005). Glutathione S-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. European Journal of Cancer, 41, 980-989.
33. Sbabrokb, M. G., Gbobadloo, M. S., Babram, Y., et al. (2004). GSTP1, GSTM1 and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis. Journal of Gastrointestinal Surgery, 4, 423-427.
34. Beeghly, A., Katsaros, D., Chen, H., et al. (2006). Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecologic Oncology, 100, 330-337.
35. Sobti, R. C., Satinder, K., Pushpinder, K., et al. (2006). Interaction of passive smoking with GST (GSTM1, GSTT1 and GSTP1) genotypes in the risk of cervical cancer in India. Cancer Genetics and Cytogenetics, 166, 117-123.